Search alternatives:
increase decrease » increased release (Expand Search), increased crash (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
increase decrease » increased release (Expand Search), increased crash (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
-
1741
Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
-
1742
-
1743
-
1744
-
1745
-
1746
-
1747
-
1748
-
1749
-
1750
-
1751
-
1752
-
1753
-
1754
-
1755
-
1756
-
1757
-
1758
-
1759
-
1760